Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer. 2009;64:1‑8.Haasbeek CJ, Slotman BJ, Senan S. Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 2009;64(1):1-8....
radiotherapysmall cell carcinomatherapyRadiotherapy is an important modality used for the treatment of lung cancer. Seventy﹕even percent of all patients with lung cancer have an evidence‐based indication for radiotherapy, although it is often underutilized. Radiotherapy can be used as curative or ...
one could specifically identify patients who might benefit from a combination of inhibitor and radiotherapy. This could be realized quickly: patients with non-small celllung cancerare already routinely
RadiotherapyRadiation therapy has evolved into an integral modality in the treatment of non-small cell lung cancer ( NSCLC ) and small cell lung cancer ( SCLC ). As technology has evolved, stereotactic body radiotherapy ( SBRT ) can now be used to achieve excellent local control in patients ...
Turin, Italy: Researchers have found that treating patients who have early stage non-small cell lung cancer (NSCLC) with a type of radiotherapy called stereotactic body radiation therapy (SBRT) is associated with a small but increased risk of death from causes other than cancer. ...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated wit
Milestones during the past decades for improving radiotherapy of lung cancer include identification of clinical prognostic parameters for stratification and individualized prescription, better anatomical visualisation of the tumour and regional lymph nodes, improved definition of the target volume, improved dosim...
Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers Camidge and Cetnar Revisit ASCO 2023 Data in Lung Cancer Reuss Reviews the Development of LP-300 in Adv...
Science (2020) 27:82 https://doi.org/10.1186/s12929-020-00676-5 REVIEW Open Access Precision radiotherapy for non-small cell lung cancer Wen-Chi Yang1,2, Feng-Ming Hsu1,2*† and Pan-Chyr Yang2,3*† Abstract Precision medicine is becoming the standard of care in anti-cancer ...
Non-small cell lung cancer LRR: Local-regional recurrence PORT: Postoperative radiotherapy DFS: Disease-free survival PP: Per-protocol OS: Overall survival IQR: Interquartile range GDP: Gross domestic product IMRT: Intensity-modulated radiotherapy LN: Lymph node ctDNA: Circulating tumor...